← Back
$MAIA All transactions

MAIA Biotechnology, Inc.

▲ BUY
5 / 10

Conviction

$ Value

$25K

Shares

19,230

Price

$1

Filed

Oct 2

Why this score? (5/10)
  • Open market buy (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Smith Stan

Title

CIK

0001913199

Roles

Director

Transaction Details

Transaction Date

2025-10-01

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

1,324,289

Footnotes

The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on October 1, 2025 | These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993. | These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on October 1, 2025. The options are exercisable beginning on the six-month anniversary of the issuance date and expire 3-years after the initial issuance date. | These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.

Filing Info

Accession No.

0001878313-25-000019

Form Type

4

Issuer CIK

0001878313

Smith Stan's History

Date Ticker Type Value
2026-03-31 MAIA A $0
2025-12-31 MAIA A $0
2025-12-22 MAIA $70K
2025-12-22 MAIA $78K
2025-12-05 MAIA $5K
2025-12-05 MAIA $5K
2025-12-05 MAIA $5K
2025-11-26 MAIA $16K
2025-11-25 MAIA $15K
2025-11-24 MAIA $10K

Other Insiders at MAIA (90d)

Insider Bought Sold Last
CHAOUKI STEVEN M 2026-03-31
Smith Stan 2026-03-31
Gryaznov Sergei
Chief Scientific Officer
2026-04-10
Guerrero Ramiro 2026-03-31
Vitoc Vlad
Chief Executive Officer
2026-04-10
Louie Ngar Yee 2026-03-31
Luput Cristian 2026-03-31
Theagene Jean-Manasse 2026-03-31
Himmelreich Jeffrey C
Head of Finance
2026-04-10